A high-flux haemodialyser designed for efficient toxin clearance, supporting the effective removal of middle and larger molecules, including various cytokines. Developed to support reliable performance during haemodialysis treatment, the Biorema® 26H provides an effective solution for the demands of modern renal care.
Designed in collaboration with cardiologists to solve the most common challenges in radial hemostasis.
With an optimised cut-off value of 40 kDa, the Biorema® 26H is designed to support the removal of cytokines, many of which are within the 17 to 33 kDa range, while minimising albumin loss.
Biorema® 26H demonstrates high sieving performance for myoglobin, a key marker for the removal of larger molecules, including cytokines. In a clinical evaluation conducted in France across 24 sessions involving 8 patients, Biorema® 26H achieved a myoglobin removal rate of >75.5%.⁸ 8. Data per manufacturer’s brochures
With an ultrafiltration (UF) coefficient of 98 ml/h/mmHg, the Biorema® 26H is designed to provide efficient ultrafiltration and support effective fluid management during haemodialysis treatment.
The Biorema® 26H is a high-flux haemodialyser developed to support efficient toxin clearance during haemodialysis. Its optimised cut-off and high permeability are designed to facilitate the removal of larger molecules, including various cytokines, while minimising albumin loss.
With a focus on effective clearance and reliable performance, the Biorema® 26H provides a clinically considered solution for modern haemodialysis therapy.
Connect with our product specialists for bulk orders and institutional inquiries.
There is no information to display.
| Product Code (Sterile) | NHS Supply Chain Product Code | Product Description |
|---|---|---|
| BIOREMA26H | FHB102 | High Flux Dialysers |
